Patients

This toolkit gives practice principles for integrated treatment for mental illness, substance use disorders, or both, and offers advice from successful programs. It includes a brochure, a PowerPoint presentation, and a introductory video.

The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

Includes an infographic guide on the benefits of three medications for alcohol use disorder and provides a brief summary of treatment planning and medications approved by the Food and Drug Administration

Provides an overview of the literature on alcohol reduction apps and the availability of evidenced-based apps on top commercial app stores

Pahola is PAHO's first artificial intelligence (AI) health specialist and the only AI digital health worker in the world that specializes in alcohol-related topics. Pahola can communicate interactively - in three languages (English, Portuguese, and Spanish) - with people about their alcohol consumption, assess their risk, help them reduce or stop alcohol use, or direct them to resources for treatment and recovery

A video series called “Short Takes with NIAAA” featuring commentary by NIAAA experts; this series consists of social media-friendly, 60-second videos explaining commonly used—but often misunderstood—alcohol terms

Provides information to consumers on medicines to treat alcohol use disorder

Compiles information on State-by-State expansion of telehealth and licensing waivers during the COVID-19 pandemic